Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.870
-0.014 (-1.59%)
Apr 29, 2026, 12:53 PM EDT - Market open
Longeveron Market Cap
Longeveron has a market cap or net worth of $25.47 million as of April 29, 2026. Its market cap has increased by 14.30% in one year.
Market Cap
25.47M
Enterprise Value
22.05M
1-Year Change
14.30%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $25.47M, a decrease of -85.23%. That is a compound annual growth rate of -30.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 25.89M | 139.82% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 27.76M |
| Lantern Pharma | 27.57M |
| NanoViricides | 26.99M |
| ABVC BioPharma | 26.69M |
| NeuroSense Therapeutics | 26.53M |
| CEL-SCI | 26.38M |
| AEON Biopharma | 26.32M |
| Quantum BioPharma | 26.07M |